by Plus Therapeutics | Nov 4, 2024 | GBM
What a great glioblastoma patient summit hosted by @glioblastomaresearch🎗️🧠 We extend our heartfelt thanks to the organization for hosting this event, as well as to all the patients and caregivers who stopped by our booth and came to Dr. Brenner’s presentation...
by Plus Therapeutics | Nov 1, 2024 | GBM
Come by our booth this weekend at @glioblastomaresearch Glioblastoma Summit in Miami; also featuring a presentation by Dr. Andrew Brenner, MD, PhD on Saturday! Our clinical and patient advocacy team will be on-site to share educational material and answer your...
by Plus Therapeutics | Oct 25, 2024 | GBM
Join us at the upcoming @glioblastomaresearch Glioblastoma Patient Summit as Plus Therapeutics takes the stage! The summit will be held November 1-3 in Miami, FL, and include panel talks from neurosurgeons and neuro-oncologists as well as an opportunity to connect...
by Plus Therapeutics | Oct 8, 2024 | GBM
#ICYMI Plus Therapeutics exhibited at the #CNS2024 Annual Meeting and Dr. John Floyd presented a ReSPECT-GBM clinical trial update Key Highlights:...
by Plus Therapeutics | Oct 1, 2024 | GBM
Plus Therapeutics presented an update on the ongoing ReSPECT-GBM Phase 1/2 clinical trial, evaluating Rhenium (186Re) Obisbemeda for the treatment of recurrent glioblastoma at the 2024 Congress of Neurological Surgeons (CNS) Annual Meeting yesterday. Key...
by Plus Therapeutics | Sep 12, 2024 | GBM
Join us at the @HeadfortheCure Caregiver Conversations support group! We will discuss our ReSPECT-GBM clinical trial for Glioblastoma, patient resources, and upcoming events. respect-trials.com/gbm Join Brains for the Cure the 2nd Thursday of each month on Zoom at 7...
Recent Comments